AI-driven healthcare solutions provider Tempus AI (TEM) has disclosed acquisition of Deep 6 AI, a precision research platform ...

We recently published a list of Top 10 Stocks Everyone Is Talking About These Days. In this article, we are going to take a ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

Cathie Wood’s ARK Investment continues to capitalize on the pullback in Tempus AI (TEM) stock by accumulating more shares, ...

CompanyOverview|NASDAQ:TEM] Tempus AI (NASDAQ: TEM) is an emerging AI player in the healthcare field with a robust outlook for long-term growth and profitability. The company uses AI to manage patient ...

Completing its initial public offering on June 14, Tempus AI stock closed at $40.25, and while it rose above this mark from time to time in the second half of 2024, the stock ended the year on a sour ...

Rep. Nancy Pelosi (D-CA) stands to make a massive profit on an options trade she made on an AI stock. The Nancy Pelosi ...

TEM basically mixes genomic and clinical data with AI. This is at the core of their new offerings for precision diagnostics and personalized treatments. Read more here.

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. It’s been a rocky few days for Tempus AI (NASDAQ:TEM).

Tempus AI's slowing growth, cash flow issues, and net debt raise doubts about its sustainability. Explore key concerns and market outlook.

Tempus AI (TEM) reports Q4 earnings Monday, expected loss of 20 cents/share, $203.12M in revenues. Stock up 98.80% YTD.

Medical imaging is a broad term that encompasses several distinct technologies. After working on AI-powered tools to enhance ...